Nalmefene for Reducing Cravings in Behavioral Addictions

We are studying whether nalmefene can help reduce craving intensity in people with behavioral addictions, such as gambling and food addiction, when added to their usual treatment.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Selincro
Selincro is a medicine that helps adults with alcohol dependence reduce their drinking.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Nalmefene
Nalmefene is a substance that blocks opioid receptors to help reduce alcohol cravings and lower drinking in people with alcohol dependence.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Chu Gabriel-Montpied
Psychiatry
Beaumont, France
Centre Hospitalier Regional Et Universitaire De Brest
Psychiatry
Brest, France
Centre Hospitalier Regional Universitaire De Tours
Psychiatry
La Riche, France

Sponsor: Centre Hospitalier Universitaire De Nantes
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.